The new data also indicates some 37 per cent of all claimants are receiving the highest rates of PIP for both the daily living and mobility components. The non-means-tested benefit provides support of ...
Kathryn Senior reports. Chimeric antigen receptor (CAR) T-cell therapies have proved effective in several haematological cancers including B-cell acute lymphoblastic leukaemia, diffuse large B-cell ...
The National Dope Testing Laboratory (NDTL) here has received approval from the World Anti-Doping Agency (WADA) to manage the Athlete Biological Passport (ABP), which is significant for the country's ...